Pak national sentenced for international wire fraud

Image
Press Trust of India Washington
Last Updated : May 24 2017 | 11:02 AM IST
A Pakistani national has been sentenced to six years' imprisonment by a federal US court for his role in an international wire fraud scheme through which he duped more than 100,000 people, the Justice Department has said.
Mustafa Hasan Arif, 37, who also holds the nationality of Britain, defrauded individuals all around the world by selling drugs that he claimed would cure many serious diseases.
According to court documents, Arif's scheme generated more than USD 12.8 million in fraudulent sales from more than 100,000 victims.
He was initially arrested after he flew into New York in February 2014 on a business trip.
He appeared in federal court in New York and later was transported to New Hampshire, where he has remained in custody.
Arif pleaded guilty to wire fraud on October 11, 2016.
According to the documents, Arif created, maintained, and controlled over 1,500 websites that promoted the sale of the drugs while he stayed in Lahore.
The websites claimed that the drugs would cure and treat hundreds of diseases, many of which were incurable, including cerebral palsy, mental retardation, Parkinson's disease, Alzheimer's disease and emphysema.
The websites included falsified cure rates, false clinical research and fabricated testimonials, federal prosecutors alleged.
One series of websites fraudulently claimed that Arif's products had shown a 90 per cent cure rate in clinical trials.
Other websites included links to clinical research that had not been written about the drugs on the websites, but which suggested that clinical research had been performed on the products Arif was distributing.
In an effort to make customers comfortable about the products, Arif also falsely represented that the drugs were being sold by entities in Germany, Norway, Italy, Australia, New Zealand, and Denmark when in fact the drugs were all being sold and shipped from Pakistan.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 24 2017 | 11:02 AM IST

Next Story